ScienceCloses Jan 1 · Results Jan 2
Will the experimental pancreatic cancer drug daraxonrasib be approved by the FDA by December 31, 2026?
30%
-1% last 24h
📊 936 bettors💎 17.6K at stake
🤖 Context
YES if the U.S. Food and Drug Administration officially grants marketing approval for daraxonrasib by December 31, 2026; NO otherwise.